AMN

SEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,079

F3 · kind: The sale of 1,002 shares of AMN Common Stock was affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in this row represents a weighted average price of $109.30 per share. These shares were sold in multiple transactions at prices ranging from $109.30 to $109.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,081

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-23-002399 · doc4.xml · derivative · entry 5

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,354

Underlying: Common Stock · 2,285 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-002399 · doc4.xml · nonDerivative · entry 4

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,901

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002399 · doc4.xml · nonDerivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,355

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 6, 2020. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2019 for the 3-year period beginning on January 1, 2020 and ended December 31, 2022 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2023. The Company's Relative TSR measured in the 89th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-23-002399 · doc4.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,605

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002399 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-23-002396 · doc4.xml · derivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,579

Underlying: Common Stock · 1,532 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,562

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,851

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 6, 2020. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2019 for the 3-year period beginning on January 1, 2020 and ended December 31, 2022 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2023. The Company's Relative TSR measured in the 89th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,739

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-22-059058 · doc4.xml · derivative · entry 2

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,329

Underlying: Common Stock · 16,329 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-22-059058 · doc4.xml · derivative · entry 1

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,164

Underlying: Common Stock · 8,164 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-22-061721 · doc4.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,115

F1 · kind: The Reporting Person transferred 300 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-22-056222 · doc4.xml · nonDerivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,139

F2 · kind: The Reporting Person transferred 855 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-22-056226 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65

F1 · balance_after: The number of shares reflected in this column does not include 34,738 vested RSUs that the Reporting Person elected to defer at the time of grant until his retirement from the Board of Directors.

SEC source: 0001209191-22-056224 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,267

F1 · kind: Reflects the gift of common stock to a charitable donor advised fund.

SEC source: 0001209191-22-056222 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,994

F1 · kind: The Reporting Person transferred 217 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-22-055688 · doc4.xml · derivative · entry 3

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,606

Underlying: Common Stock · 9,656 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on November 2, 2021 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-22-055688 · doc4.xml · nonDerivative · entry 2

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,333

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-055688 · doc4.xml · nonDerivative · entry 1

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-22-050917 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,588

F2 · kind: Number of shares withheld for tax purposes.

F3 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-22-050917 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,577

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-22-048050 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,267

F1 · kind: The sale of 6,330 shares of Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $107.09 per share. These shares were sold in multiple transactions at prices ranging from $106.59 to $107.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-046758 · doc4.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,080

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-046758 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,720

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on August 15, 2021. The number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of August 15, 2021 comparing the average closing price for the 90-day period prior to August 15, 2021 to the period prior to August 15, 2022 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on August 16, 2022. The Company's Relative TSR measured in the 86th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-22-046755 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,597

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-046755 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,642

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on August 15, 2021. The number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of August 15, 2021 comparing the average closing price for the 90-day period prior to August 15, 2021 to the period prior to August 15, 2022 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on August 16, 2022. The Company's Relative TSR measured in the 86th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-22-034807 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,345

F1 · price: The price reported in this row represents a weighted average price of $97.5257 per share. These shares were sold in multiple transactions at prices ranging from $97.525 to $97.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-025448 · doc4.xml · derivative · entry 1

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025451 · doc4.xml · derivative · entry 3

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025451 · doc4.xml · derivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,139 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022, which will be held on May 6, 2022. Accordingly, the number of RSUs identified in this row vested on April 21, 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025451 · doc4.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-22-025446 · doc4.xml · derivative · entry 3

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023. At the reporting person's irrevocable election, the number of Restricted Stock Units identified in this row will settle on the date of the director's separation from service with the Company.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025446 · doc4.xml · derivative · entry 2

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on December 14, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022. Accordingly, the number of RSUs identified in this row vested on April 21, 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025446 · doc4.xml · nonDerivative · entry 1

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-22-025442 · doc4.xml · derivative · entry 3

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025442 · doc4.xml · derivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,139 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022, which will be held on May 6, 2022. Accordingly, the number of RSUs identified in this row vested on April 21, 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025442 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,211

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-22-025438 · doc4.xml · derivative · entry 1

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023. At the reporting owner's irrevocable election, the number of Restricted Stock Units identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025435 · doc4.xml · derivative · entry 3

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025435 · doc4.xml · derivative · entry 2

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,139 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022, which will be held on May 6, 2022. Accordingly, the number of RSUs identified in this row vested on April 21, 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025435 · doc4.xml · nonDerivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,040

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-22-025432 · doc4.xml · derivative · entry 3

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025432 · doc4.xml · derivative · entry 2

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,139 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022, which will be held on May 6, 2022. Accordingly, the number of RSUs identified in this row vested on April 21, 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025432 · doc4.xml · nonDerivative · entry 1

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-22-025430 · doc4.xml · derivative · entry 3

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458

Underlying: Common Stock · 1,458 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-22-025430 · doc4.xml · derivative · entry 2

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,139 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022, which will be held on May 6, 2022. Accordingly, the number of RSUs identified in this row vested on April 21, 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.